Literature DB >> 22590962

[Case of HIV-associated nephropathy accompanied by nephrotic syndrome and acute worsening of kidney function].

Tomonori Kimura1, Keiko Yasuda, Yoshitsugu Obi, Toshihiro Satoh, Tomoko Namba, Koichi Sasaki, Noriko Muramoto, Akira Wada, Hiromi Rakugi, Yoshitaka Isaka, Terumasa Hayashi.   

Abstract

A previously healthy black man presented with acute kidney injury wtih nephrotic syndrome. His serum creatinine and albumin concentrations were 8.0 mg/dL and 0.4 g/dL, respectively. Renal ultrasound demonstrated an enlarged kidney with an extremely high echogenic cortex. Human immunodeficiency virus (HIV) was serologically positive, and kidney biopsy revealed a collapsing variant of focal segmental glomerulosclerosis with interstitial nephritis. He was diagnosed as having HIV-associated nephropathy (HIVAN). Although there have been only a few cases with characteristic HIVAN features in Japan, the number of patients with HIVAN who need dialysis treatment is relatively high globally, and is expected to increase even in Japan. The rapid clinical course of HIVAN, along with its characteristic histology and the direct pathogenesis of HIV on podocytes, is noteworthy. We described this case with reference to some recent findings.

Entities:  

Mesh:

Year:  2012        PMID: 22590962

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  3 in total

1.  Collapsing glomerulopathy with rare associated coxsackie virus infection: A case report.

Authors:  Xuejing Zhu; Hong Liu; Shuguang Yuan; Xiangqing Xu; Zhen Dong; Fuyou Liu
Journal:  Exp Ther Med       Date:  2016-03-15       Impact factor: 2.447

2.  Clinical remission of IgA nephropathy in an HIV-positive patient after combined treatment with tonsillectomy and steroid pulse therapy.

Authors:  Manami Tada; Shoichi Masumoto; Fumihiko Hinoshita
Journal:  CEN Case Rep       Date:  2014-11-19

3.  Acute kidney injury in patients with primary nephrotic syndrome: influencing factors and coping strategies.

Authors:  Honghua Lu; Liping Xiao; Mengqi Song; Xiaolan Liu; Fang Wang
Journal:  BMC Nephrol       Date:  2022-03-05       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.